Tandem Investment Advisors, Inc. Abbott Laboratories Transaction History

Tandem Investment Advisors, Inc.

$2.64 Billion
Q3 2024

A detailed history of Tandem Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Tandem Investment Advisors, Inc. holds 992,412 shares of ABT stock, worth $113 Million. This represents 4.29% of its overall portfolio holdings.

Number of Shares

992,412

Previous 996,326 0.39%

Holding current value

$113 Million

Previous $104 Million 9.29%

% of portfolio

4.29%

Previous 4.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$100.07 - $118.13 $391,673 - $462,360	-3,914 Reduced 0.39%	992,412 $113 Million
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $3.25 Million - $3.63 Million	32,247 Added 3.34%	996,326 $104 Million
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $5.21 Million - $5.75 Million	47,539 Added 5.19%	964,079 $110 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $4.22 Million - $5.17 Million	-46,814 Reduced 4.86%	916,540 $101 Million
Q3 2023 Oct 30, 2023	BUY	$95.53 - $114.62 $4.7 Million - $5.64 Million	49,171 Added 5.38%	963,354 $93.3 Million
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $5.29 Million - $5.89 Million	52,492 Added 6.09%	914,183 $99.7 Million
Q1 2023 Jul 18, 2023	BUY	$96.86 - $114.01 $12.4 Million - $14.6 Million	127,654 Added 17.39%	861,691 $87.3 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $829,493 - $973,123	-8,726 Reduced 1.17%	734,037 $80.6 Million
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $5.26 Million - $6.09 Million	54,352 Added 7.9%	742,763 $71.9 Million
Q2 2022 Sep 14, 2022	BUY	$102.07 - $123.37 $2.27 Million - $2.74 Million	22,191 Added 3.33%	688,411 $74.8 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $7.68 Million - $9.37 Million	67,395 Added 11.25%	666,220 $78.9 Million
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $3.41 Million - $4.18 Million	29,558 Added 5.19%	598,825 $84.3 Million
Q3 2021 Oct 15, 2021	BUY	$116.66 - $129.06 $3.55 Million - $3.93 Million	30,415 Added 5.64%	569,267 $67.2 Million
Q2 2021 Jul 12, 2021	BUY	$105.79 - $124.53 $3.31 Million - $3.89 Million	31,249 Added 6.16%	538,852 $62.5 Million
Q1 2021 Apr 13, 2021	BUY	$108.84 - $128.23 $7.36 Million - $8.68 Million	67,665 Added 15.38%	507,603 $60.8 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $3.62 Million - $3.94 Million	34,448 Added 8.5%	439,938 $48.2 Million
Q3 2020 Oct 14, 2020	BUY	$91.64 - $111.29 $2.26 Million - $2.75 Million	24,704 Added 6.49%	405,490 $44.1 Million
Q2 2020 Jul 30, 2020	SELL	$76.57 - $98.0 $5.76 Million - $7.38 Million	-75,288 Reduced 16.51%	380,786 $34.8 Million
Q1 2020 Apr 14, 2020	BUY	$62.82 - $91.86 $3.37 Million - $4.93 Million	53,713 Added 13.35%	456,074 $36 Million
Q4 2019 Jan 15, 2020	BUY	$78.51 - $87.4 $1.07 Million - $1.19 Million	13,634 Added 3.51%	402,361 $34.9 Million
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $2.37 Million - $2.57 Million	29,004 Added 8.06%	388,727 $32.5 Million
Q2 2019 Jul 17, 2019	BUY	$72.88 - $85.0 $2.22 Million - $2.59 Million	30,486 Added 9.26%	359,723 $30.3 Million
Q1 2019 Apr 15, 2019	BUY	$66.22 - $80.06 $1.84 Million - $2.23 Million	27,818 Added 9.23%	329,237 $26.3 Million
Q4 2018 Jan 25, 2019	BUY	$65.56 - $74.27 $2.49 Million - $2.82 Million	37,910 Added 14.39%	301,419 $21.8 Million
Q3 2018 Oct 15, 2018	BUY	$60.81 - $73.36 $17,270 - $20,834	284 Added 0.11%	263,509 $19.3 Million
Q2 2018 Jul 05, 2018	BUY	$57.57 - $63.54 $51,640 - $56,995	897 Added 0.34%	263,225 $16.1 Million
Q1 2018 Apr 03, 2018	BUY	$56.27 - $63.62 $1.1 Million - $1.24 Million	19,504 Added 8.03%	262,328 $15.7 Million
Q4 2017 Jan 09, 2018	BUY	$53.68 - $57.47 $13 Million - $14 Million	242,824	242,824 $13.9 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tandem Investment Advisors, Inc. with notifications on news.

Account

Tandem Investment Advisors, Inc. Abbott Laboratories Transaction History